1. Home
  2. SENS

as 11-18-2025 3:37pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Industrials

Industrial Machinery/Components

Nasdaq

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Founded: 1996 Country:
United States
United States
Employees: N/A City: GERMANTOWN
Market Cap: 255.8M IPO Year: N/A
Target Price: $25.58 AVG Volume (30 days): 537.3K
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.65 EPS Growth: N/A
52 Week Low/High: $5.00 - $28.00 Next Earning Date: 11-05-2025
Revenue: $29,298,000 Revenue Growth: 31.94%
Revenue Growth (this year): 63.07% Revenue Growth (next year): 73.56%

SENS Daily Stock ML Predictions

Stock Insider Trading Activity of Senseonics Holdings Inc. (SENS)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Steven Edelman SENS Director Nov 10 '25 Buy $6.55 10,000 $65,500.00 74,708
Goodnow Timothy T SENS President and CEO Nov 7 '25 Buy $5.87 17,210 $101,022.70 661,085
Sullivan Frederick T. SENS Chief Financial Officer Nov 7 '25 Buy $5.88 5,415 $31,840.20 157,028
ROEDER DOUGLAS A SENS Director Nov 7 '25 Buy $5.83 15,000 $87,450.00 99,727

Share on Social Networks: